智能气球:一种集成的方法来开发一种含有everolimus的药物涂层气球
概括
药物涂层气球 (DCB) 为冠状动脉疾病的支架提供了一个创新的替代方案. 这项研究提出了一种综合方法,使用体内,体外和体内的方法来优化一种新的常释放的DCB.
科学领域:
- 心血管医学 心血管医学
- 生物材料科学 生物材料科学
- 医疗设备工程 医疗设备工程
背景情况:
- 冠状动脉疾病 (CAD) 带来了显著的死亡和发病风险.
- 药物排泄支架是常见的,但药物涂层气球 (DCB) 提供了一个替代方案,特别是在特定的血管疾病中.
- 在膨胀过程中,DCB促进了对动脉壁的快速,均的药物输送.
研究的目的:
- 为设计和开发一种使用everolimus的创新药物涂层气球 (DCB) 提出一个综合的方法.
- 通过结合体内,体外和体内的方法来优化DCB性能.
- 为了使开发过程与动物和临床研究的3Rs原则 (取代,减少,改进) 保持一致.
主要方法:
- 开发一种包含everolimus的新型DCB.
- 利用体内研究来评估生物环境中的性能.
- 在体外测试的应用,用于对DCB特征的受控评估.
- 实施in silico建模用于DCB设计的预测分析和优化.
- 整合所有三种方法来完善DCB开发过程.
主要成果:
- 该研究提出了DCB开发的综合方法.
- 综合方法允许系统优化DCB设计参数.
- 该方法遵循道德原则,尽量减少动物和临床试验.
结论:
- 一个集成的体内,体外和体内方法是有效的开发创新的药物涂层气球.
- 这种综合策略增强了DCB的优化过程,例如新型常释出DCB的DCB.
- 提出的方法支持3R原则,为更高效,更道德的医疗器械开发铺平了道路.
相关概念视频
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant, half-life,...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...